Sign In
Free Newsletter
The Nod from Nasdaq
Jessica Perry//February 3, 2006
Biz BriefsSavient Pharmaceuticals has received notification from the Nasdaq Listings Qualification Panel that it will continue to be listed as a public company on the Nasdaq National Market. Its status on the Nasdaq traded under the symbol SVNTÂhad come into question last year because of its failure to file two quarterly reports for 2005, amendments to a 2005 quarterly report and its annual report for 2004 with the Securities and Exchange Commission. The East Brunswick-based specialty pharmaceutical company had asked for extensions on all four filings.
